Clinical Trials Directory

Trials / Completed

CompletedNCT00524147

Drainage of Tuberculous Pleural Effusions

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
64 (actual)
Sponsor
Taipei Medical University Hospital · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

Tuberculous (TB) pleurisy can cause clinical symptoms and pleural fibrosis with resultant residual pleural thickening (RPT). Therapeutic thoracentesis or initial complete drainage in addition to anti-TB drugs have been tried to rapidly relieve dyspnea caused by effusion and to decrease the occurrence of RPT. However, contradictory results are reported without clear reasons. The researchers' hypothesis is that, in addition to anti-TB medications, early effective evacuation of inflammatory exudates with or without fibrinolytic agents may hasten resolution of pleural effusion, reduce the occurrence of RPT and finally improve long-term functional outcome in patients with TB pleurisy.

Conditions

Interventions

TypeNameDescription
PROCEDUREPigtail drainage

Timeline

Start date
2003-10-01
Primary completion
2005-10-01
Completion
2006-12-01
First posted
2007-09-03
Last updated
2010-12-30

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT00524147. Inclusion in this directory is not an endorsement.